Floatz logo

271 assets in Renal Cell Carcinoma

Therapeutic assets addressing Renal Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pazopanib
Renal Cell Carcinoma
Imbioray (Hangzhou) Biomedicine Co., Ltd.P4BBB (79)
Belzutifan
Renal Cell Carcinoma
Vall d'Hebron Institute of OncologyP3BBB (73)
Atorvastatin
Renal Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3BB (69)
Everolimus
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP4BB (69)
Nivolumab
Renal Cell Carcinoma
Fred Hutchinson Cancer CenterP4BB (69)
Capecitabine
Renal Cell Carcinoma
Oliver JonasP3BB (68)
Adriamycin
Renal Cell Carcinoma
Oliver JonasP2BB (67)
Axitinib
Renal Cell Carcinoma
SWOG Cancer Research NetworkP4BB (67)
Ipilimumab
Renal Cell Carcinoma
SWOG Cancer Research NetworkP4BB (67)
Olaparib
Renal Cell Carcinoma
Oliver JonasP4BB (67)
Pembrolizumab
Renal Cell Carcinoma
City of Hope Medical CenterP4BB (67)
Sulfur Hexafluoride
Renal Cell Carcinoma
john eisenbreyP4BB (67)
Toripalimab
Renal Cell Carcinoma
Jinling Hospital, ChinaP3BB (67)
Clostridium Butyricum Miyairi 588
Renal Cell Carcinoma
City of Hope Medical CenterP3BB (66)
Cyclophosphamide
Renal Cell Carcinoma
City of Hope Medical CenterP3BB (66)
Enzalutamide
Renal Cell Carcinoma
ExelixisP3BB (66)
Girentuximab
Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty LimitedP3BB (66)
Prednisone
Renal Cell Carcinoma
ExelixisP3BB (66)
Vipivotide Tetraxetan
Renal Cell Carcinoma
Ankara UniversityP3BB (66)
Propofol
Renal Cell Carcinoma
Seoul National University HospitalP4BB (65)
Zanzalintinib
Renal Cell Carcinoma
City of Hope Medical CenterP3BB (65)
Cabozantinib
Renal Cell Carcinoma
SWOG Cancer Research NetworkP4BB (64)
Immunoglobulin G1, Anti-(Human Cytotoxic T-Lymphocyte-Associated Antigen 4) (Human-Mus Musculus Monoclonal M3 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal M3 .Kappa.-Chain, Dimer
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP3BB (64)
Lenvatinib
Renal Cell Carcinoma
SWOG Cancer Research NetworkP4BB (64)
Palbociclib
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP4BB (64)
Regorafenib
Renal Cell Carcinoma
Neonc Technologies, Inc.P2BB (64)
Sevoflurane
Renal Cell Carcinoma
Seoul National University HospitalP4BB (64)
Volitinib
Renal Cell Carcinoma
AstraZenecaP3BB (64)
Retifanlimab
Renal Cell Carcinoma
University of California, San DiegoP2B (63)
Docetaxel
Renal Cell Carcinoma
NuCana plcP3B (62)
Fludarabine
Renal Cell Carcinoma
Canadian Cancer Trials GroupP2B (62)
Irinotecan
Renal Cell Carcinoma
Toray Industries, IncP2B (62)
Lidocaine
Renal Cell Carcinoma
University Hospital of SplitP3B (62)
Tivozanib
Renal Cell Carcinoma
City of Hope Medical CenterP3B (62)
Atezolizumab
Renal Cell Carcinoma
ExelixisP3B (61)
Fluorouracilum
Renal Cell Carcinoma
Neonc Technologies, Inc.P2B (61)
Vorolanib
Renal Cell Carcinoma
Peking University Cancer Hospital & InstituteP3B (61)
Cis-Diamminedichloroplatinum Ii
Renal Cell Carcinoma
Inhibrx Biosciences, IncP2B (60)
Denosumab
Renal Cell Carcinoma
Kelly Fitzgerald, MDP3B (60)
Durvalumab
Renal Cell Carcinoma
M.D. Anderson Cancer CenterP3B (60)
Envafolimab
Renal Cell Carcinoma
Peking Union Medical College HospitalP2B (60)
Fruquintinib
Renal Cell Carcinoma
Sun Yat-sen UniversityP2/3B (60)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Renal Cell Carcinoma
Novartis PharmaceuticalsP2B (60)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer
Renal Cell Carcinoma
Washington University School of MedicineP3B (60)
Recombinant Human Hyaluronidase
Renal Cell Carcinoma
SWOG Cancer Research NetworkP3B (60)
Carboplatin
Renal Cell Carcinoma
Shanghai Henlius BiotechP2B (59)
Ciforadenant
Renal Cell Carcinoma
M.D. Anderson Cancer CenterP1/2B (59)
Obinutuzumab
Renal Cell Carcinoma
Simcha IL-18, Inc.P2B (58)
Vebreltinib
Renal Cell Carcinoma
Apollomics (Australia) Pty. Ltd.P2B (58)
Abiraterone
Renal Cell Carcinoma
ExelixisP3B (57)
Showing 1 to 50 of 271 assets
PreviousPage 1 of 6Next